RYN vs. PCH, BCC, WY, OHI, CUBE, RHP, HR, EPR, SBRA, and GEO
Should you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Potlatch (PCH), Boise Cascade (BCC), Weyerhaeuser (WY), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), EPR Properties (EPR), Sabra Healthcare REIT (SBRA), and Geo Group (GEO).
Rayonier vs. Its Competitors
Potlatch (NASDAQ:PCH) and Rayonier (NYSE:RYN) are both mid-cap construction companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.
In the previous week, Rayonier had 6 more articles in the media than Potlatch. MarketBeat recorded 10 mentions for Rayonier and 4 mentions for Potlatch. Potlatch's average media sentiment score of 1.35 beat Rayonier's score of 0.29 indicating that Potlatch is being referred to more favorably in the media.
Potlatch currently has a consensus target price of $48.57, suggesting a potential upside of 23.03%. Rayonier has a consensus target price of $27.75, suggesting a potential upside of 21.72%. Given Potlatch's stronger consensus rating and higher possible upside, research analysts clearly believe Potlatch is more favorable than Rayonier.
Rayonier has higher revenue and earnings than Potlatch. Rayonier is trading at a lower price-to-earnings ratio than Potlatch, indicating that it is currently the more affordable of the two stocks.
Rayonier has a net margin of 30.09% compared to Potlatch's net margin of 4.35%. Rayonier's return on equity of 3.29% beat Potlatch's return on equity.
Potlatch has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, Rayonier has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.
86.1% of Potlatch shares are held by institutional investors. Comparatively, 89.1% of Rayonier shares are held by institutional investors. 1.0% of Potlatch shares are held by company insiders. Comparatively, 0.8% of Rayonier shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Potlatch pays an annual dividend of $1.80 per share and has a dividend yield of 4.6%. Rayonier pays an annual dividend of $1.09 per share and has a dividend yield of 4.8%. Potlatch pays out 295.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Rayonier pays out 46.8% of its earnings in the form of a dividend. Rayonier is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Rayonier beats Potlatch on 10 of the 18 factors compared between the two stocks.
Get Rayonier News Delivered to You Automatically
Sign up to receive the latest news and ratings for RYN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RYN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Rayonier Competitors List
Related Companies and Tools
This page (NYSE:RYN) was last updated on 7/2/2025 by MarketBeat.com Staff